The ACT EU workplan for 2025-2026 is now available.
The revised workplan highlights ACT EU’s areas of focus over the next two years, reflecting the feedback received through the multi-stakeholder platform advisory group and other channels:
- The operation of the Clinical Trials Regulation.
- Maximising the impact of clinical trials.
- Clinical trials in public health emergencies.
Clinical trial analytics, training, and communication remain integral to ACT EU’s work, and interlinked with all other activities.
For more details, see: ACT EU workplan 2025-2026
- Datum der Veröffentlichung
- 20. Januar 2025
- Autor
- Europäische Arzneimittel-Agentur
